다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of hepatology : the journal of the European Association for the Study of the Liver, v.23 no.3, 1995년, pp.259 - 267
Siersema, P.D. , Rademakers, L.H.P.M. , Cleton, M.L. , ten Kate, F.J.W. , de Bruijn, W.C. , Marx, J.J.M. , Paul Wilson, J.H.
AI-Helper
Porphyria cutanea tarda is a disorder of porphyrinmetabolism, of which familial and sporadic forms have been described. Factors such as iron seem necessary for porphyria cutanea tarda to become clinically manifest. To study the relationship between iron and uroporphyrins in hepatocytes of patients w...
Kappas 1305 1989 The Metabolic Basis of Inherited Disease The porphyrias
J Clin Invest Kushner 58 1089 1976 10.1172/JCI108560 An inherited enzymatic defect in porphyria cutanea tarda. Decreased uroporphyrinogen decarboxylase activity
Hum Genet De Verneuil 44 145 1978 10.1007/BF00295407 Familial and sporadic porphyria cutanea tarda. Two different diseases
N Engl J Med Elder 299 274 1978 10.1056/NEJM197808102990603 Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda
N Engl J Med Felsher 306 766 1982 10.1056/NEJM198204013061302 Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda
Clin Chem Siersema 36 1779 1990 10.1093/clinchem/36.10.1779 Erythrocyte porphobilinogen deaminase activity in porphyria cutanea tarda
Am J Med Grossman 67 277 1979 10.1016/0002-9343(79)90403-0 Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients
Semin Dermatol Mascaro 5 115 1986 Uroporphyrinogen decarboxylase deficiencies, porphyria cutanea tarda and related conditions
Am J Obstet Gynecol Baxi 146 333 1983 10.1016/0002-9378(83)90757-3 Porphyria cutanea tarda and pregnancy
Arch Dermatol Res Sixel-Dietrich 278 13 1985 10.1007/BF00412489 Hereditary uroporphyrinogen decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oralcontraceptive medication
J Hepatol Salata 1 477 1985 10.1016/S0168-8278(85)80746-7 Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors
Liver Rocchi 6 153 1986 10.1111/j.1600-0676.1986.tb00282.x Hepatitis B infection in porphyria cutanea tarda
Hepatology Fargion 16 1322 1992 10.1002/hep.1840160603 Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association
Lancet Herrero 341 788 1993 10.1016/0140-6736(93)90562-U Is hepatitis C virus infection a trigger of porphyria cutanea tarda?
Dtsch Med Wochenschr Ippen 86 127 1961 10.1055/s-0028-1112755 Allgemeinsymptome der spdten Hautporphyrie (Porphyia cutanea tarda) als Hinweise far deren Behandlung
Acta Med Scand Lundvall 184 191 1968 10.1111/j.0954-6820.1968.tb02443.x Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda
N Engl J Med Epstein 279 1301 1968 10.1056/NEJM196812122792402 Porphyria cutanea tarda. A study of the effect of phlebotomy
Acta Med Scand Lundvall 188 37 1970 10.1111/j.0954-6820.1970.tb08003.x Iron storage in porphyria cutanea tarda
Int J Biochem Enriquez 12 861 1980 10.1016/0020-711X(80)90175-5 Patterns of porphyrin excretion in porphyria cutanea tarda under venesection treatment
J Lab Clin Med Rocchi 107 36 1986 Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda
Dermatologica Rocchi 182 27 1991 10.1159/000247732 Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda
Liver Siersema 12 56 1992 10.1111/j.1600-0676.1992.tb00557.x Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence
Acta Med Scand Lundvall 189 51 1971 10.1111/j.0954-6820.1971.tb04338.x The effect of replenishment of iron stores after phlebotomy therapy in porphyria cutanea tarda
S Afr Med J Timme 48 1803 1974 Symptomatic porphyria. Part 1. The pathology of the liver in human symptomatic porphyria
Histopathology Cortes 4 471 1980 10.1111/j.1365-2559.1980.tb02942.x The pathology of the liver in porphyria cutanea tarda
Liver Lelkowitch 3 19 1983 10.1111/j.1600-0676.1983.tb00846.x Hepatic pathology in porphyria cutanea tarda
Arch Pathol Waldo 96 368 1973 Needle-like cytoplasmic inclusions in the liver in porphyria cutanea tarda
J Clin Pathol James 33 899 1980 10.1136/jcp.33.9.899 Demonstration of intracytoplasmic needle-like inclusions in hepatocytes of patients with porphyria cutanea tarda
Zentralbl Allg Pathol Kemmer 127 253 1983 Zur Bedeutung parakristalliner Nadelstrukturen fur die Diagnose der chronischen hepatischen Porphyrie - licht- and elektronenmikroskopischeUntersuchungen an Biopsiematerial
Virchows Arch B Pathol Anat Histopathol Fakan 411 365 1987 10.1007/BF00713382 Demonstration of needle-like inclusions in porphyria cutanea tarda using the ferric ferricyanide reduction test
Acta Histochem (Jena) Petryka 63 168 1978 10.1016/S0065-1281(78)80022-1 Location of iron and porphyrin in the liver in porphyria cutanea tarda
Hepatology Siersema 14 1179 1991 10.1002/hep.1840140637 Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: a biochemical and morphological study
Cell Tissue Res Siersema 274 405 1993 10.1007/BF00318759 Ferritin-iron accumulation and uroporphyrin (crystal) formation in hepatocytes of C57BL/10 mice: a time-course study
Clin Chem Alleman 28 1144 1982 10.1093/clinchem/28.5.1144 Familial porphyria cutanea tarda: the pattern of porphyrins found from porphobilinogen by hemolysates
Clin Chim Acta Wilson 89 165 1978 10.1016/0009-8981(78)90373-X Preparation of porphyrin methyl esters for high pressure liquid chromatography
Lillie 235 1976 Histopathologic Technic and Practical Histochemistry
J Pathol Bacteriol Scheuer 84 53 1962 10.1002/path.1700840107 Hepatic pathology in relatives of patients with haemochromatosis
Ploem 405 1975 Mononuclear Phagocytes in Immunity, Infection and Pathology Reflection contrast microscopy as a tool for investigation of the attachment of living cells to a glass surface
Histochemistry Cornelese-ten Velde 94 61 1990 10.1007/BF00266791 New sensitive light microscopical detection of colloidal gold on ultrathin sections by reflection contrast microscopy: combination of reflection contrast and electron microscopy in post-embedding immunogold histochemistry
Cell Tissue Res Cleton 256 601 1989 10.1007/BF00225610 Effect of phlebotomy on the ferritin iron content in the rat liver as determined morphometrically with the use of electron energy loss spectroscopy
Ultramicroscopy Sorber 32 55 1990 10.1016/0304-3991(90)90094-3 Quantitative energy-filtered image analysis in cytochemistry. 1. Morphometric analysis of contrast-related images
Ultramicroscopy Sorber 32 69 1990 10.1016/0304-3991(90)90095-4 Quantitative energy-filtered image analysis in cytochemistry. 11. Morphometric analysis of elementdistribution images
Hepatology Cleton 6 848 1986 10.1002/hep.1840060507 Determination of iron to phosphorus ratios of iron storage compounds in patients with iron overload: a chemical and electron probe X-ray microanalysis
Gastroenterology Deugnier 102 2050 1992 10.1016/0016-5085(92)90331-R Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations
Hepatology Zuyderhoudt 3 232 1983 10.1002/hep.1840030216 The amount of ferritin and hemosiderin in the livers of patients with iron-loading diseases
J Clin Invest Kushner 56 661 1975 10.1172/JCI108136 The role of iron in the pathogenesis of porphyria cutanea tarda. II Inhibition of uroporphyrinogen decarboxylase
Biochemistry Straka 22 4664 1983 10.1021/bi00289a009 Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase
Gastroenterology Mukerji 87 1248 1984 10.1016/0016-5085(84)90189-6 Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyriacutanea tarda
Arch Biochem Biophys Mukerji 244 619 1986 10.1016/0003-9861(86)90630-2 In vitro studies of the mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron under anaerobic conditions
Biochem J Smith 214 909 1983 10.1042/bj2140909 Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice
Biochem J Ferioli 224 769 1984 10.1042/bj2240769 Drug-induced accumulation of uroporphyrin in chicken hepatocyte cultures. Structural requirements for the effect and role of exogenous iron
Biochem Pharmacol Alleman 34 161 1985 10.1016/0006-2952(85)90118-2 The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria
Mol Aspects Med Halliwel 8 89 1985 10.1016/0098-2997(85)90001-9 The importance of free radicals and catalytic metal ions in human diseases
Biochem Pharmacol Urquhart 36 3795 1987 10.1016/0006-2952(87)90439-4 Hexachlorobenzene-induced oxygen activation by mouse liver microsomes: comparison with phenobarbitone and 20-methylcholanthrene
Biochem J De Matteis 250 161 1988 10.1042/bj2500161 Increased oxidation of uroporphyrinogen by an inducible liver microsomal system. Possible relevance to drug-induced uroporphyria
J Biochem Toxicol Rizzardini 3 33 1988 10.1002/jbt.2570030105 Investigations on the role of free radical processes in hexachlorobenzene-induced porphyria in mice
Drug Metab Rev Samokyszyn 19 283 1988 10.3109/03602538808994137 Release of iron from ferritin and its role in oxygen radical toxicities
Food Chem Toxicol Visser 27 317 1989 10.1016/0278-6915(89)90134-8 Development of hexachlorobenzene porphyria in rats: time sequence and relationship with lipid peroxidation
Xenobiotica Smith 20 865 1990 10.3109/00498259009046902 Oxidative injury mediated by the hepatic cytochrome P-450 system in conjunction with cellular iron. Effects on the pathway of haem biosynthesis
Arch Biochem Biophys Mukerji 281 177 1990 10.1016/0003-9861(90)90429-3 Free radical mechanism of oxidation of uroporphyrinogen in the presence of ferrous iron
Int J Biochem Rios de Molina M del 12 1027 1980 10.1016/0020-711X(80)90206-2 Investigations on the presence of porphyrinogen carboxy-lyase inhibitor in the liver of rats intoxicated with hexachlorobenzene
Toxicol Lett Cantoni 20 211 1984 10.1016/0378-4274(84)90149-8 In vitro inhibitory effect on porphyrinogen carboxylase of liver extracts from TODD treated mice
Biochem J Smith 246 221 1987 10.1042/bj2460221 Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload
FEBS Lett Francis 233 311 1988 10.1016/0014-5793(88)80449-6 Oxidation of uroporphyrinogens by hydroxyl radicals. Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase
Can J Physiol Pharmacol Green-Thompson 70 939 1992 10.1139/y92-128 Inhibition of chick embryo hepatic uroporphyrinogen decarboxylase by components of xenobiotic-treated chick embryo hepatocytes in culture. II
Biochem Pharmacol Van Gelder 46 221 1993 10.1016/0006-2952(93)90407-N The effect of desferrioxamine on iron metbaolism and lipid peroxidation in hepatocytes of C57BL/10 mice in experimental uroporphyria
Lancet Elder i 229 1985 10.1016/S0140-6736(85)90287-9 Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda
Clin Biochem Elder 22 163 1989 10.1016/S0009-9120(89)80072-4 Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects
FEBS Lett Mukerji 189 217 1985 10.1016/0014-5793(85)81026-7 A potential biochemical explanation for the genesis of porphyria cutanea tarda. Studies on the inherent biochemical defect in highly purified humanerythrocyte uroporphyrinogen decarboxylase and its amplification by iron
N Engl J Med Niederau 313 1256 1985 10.1056/NEJM198511143132004 Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.